Lastly, measuring aggregates in human tissue would be the definitive experiment, but the SOD1 mutations account for a very small number of ALS cases (~2.5%) so the amount human tissue available is very limited. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.